Cost of childhood acute lymphoblastic leukemia care in Shanghai, China

Pediatric Blood and Cancer

Volumn 53, Issue 4, 2009, Pages 557-562

  Liu, Yin ^a   Chen, Jing ^a   Tang, JingYan ^a   Ni, Shengxing ^a   Xue, Huiliang ^a   Pan, Ci ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute; Childhood; Costs; Leukemia; Lymphoblastic

Indexed keywords

ASPARAGINASE; CHINESE DRUG; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHINA; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMMON COLD; CONSTIPATION; COST BENEFIT ANALYSIS; COST OF ILLNESS; COUGHING; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEMALE; HEALTH CARE COST; HOME CARE; HOSPITALIZATION; HUMAN; LEUKEMIA REMISSION; MALE; ONCOLOGY WARD; PRE B LYMPHOCYTE; PRE T LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION; ECONOMICS; INFANT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 69849108261     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22127     Document Type: Article

References (12)

1. Tang Y, Xu X, Song H, et al. Long-term outcome of childhood acute lymphoblastic leukemia treated in China. Pediatr Blood Cancer 2008;513:380-386.
2. Wagner HP, Antic V. The problem of paediatric malignancies in the developing world. Ann NY Acad Sci 1997;824:193-204. (Pubitemid 27480407)
3. Williams JA, Ribeiro RC. Paediatric haematology-oncology outreach for developing countries. Hematol Oncol Clin North Am 2001;15:775-787. (Pubitemid 32959259)
4. Ross JA, Olshan AF. Paediatric cancer in the United States: The Children's Oncology Group Epidemiology Research Program. Cancer Epidemiol Biomarkers Prev 2004;1310:1552-1554.
5. Lu M, Zhang J, Ma J, et al. Child health insurance coverage: A survey among temporary and permanent residents in Shanghai. BMC Health Serv Res 2008;17:238.
6. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;15:730-751. (Pubitemid 34194843)
7. Liu CZ, Chen DW. Sanhuang tablets research. Zhongguo Zhong Yao Za Zhi 2007;3217:1827-1829.
8. National Bureau of Statistics. People's Republic of China. China development report 2008. China Statistics Press; 2008. pp 312-313.
9. Tang JY, Gu LJ, Xue HL, et al. Report on induction quality, risk and middle term follow up of childhood acute lymphoblastic leukemia. Chin J Hematol 2009;30:289-293.
10. Xue-Qun Luo, Zhi-Yong Ke, Xiao-Qing Guan, et al. The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China. Pediatr Blood Cancer 2008;51:204-209.
11. Pui CH, Sandlund JT, Pei D, et al. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA 2003:15:2001-2007. (Pubitemid 37430582)
12. Hisashige A. Cost-effectiveness of cancer therapy. Gan-To-Kagaku-Ryoho 2000;279:1347.